Diagnostics

Hematology

New insights about how 'bad' cholesterol works in the body

LABline

Dec. 12, 2024

Findings could pave the way for more personalized treatments for cardiovascular disease.

Diagnostics

MeMed awarded FDA Breakthrough Device Designation

LABline

Dec. 11, 2024

Diagnostics

GlobalData’s breast cancer diagnostics market forecast

LABline

Dec. 9, 2024

Diagnostics

WHO announces first prequalification of a tuberculosis diagnostic test

LABline

Dec. 5, 2024

Diagnostics

Abnormal prenatal blood test results could indicate hidden maternal cancers

LABline

Dec. 5, 2024

Hematology

Predicting cardiac issues in cancer survivors using a serum protein panel test

LABline

Dec. 4, 2024

Diagnostics

Biofidelity launches Aspyre clinical test for lung

LABline

Nov. 22, 2024

Simple, fast, reliable detection of non-small cell lung cancer biomarkers from tissue or blood.

Diagnostics

Rise in pancreatic cancer cases among young adults may be overdiagnosis

LABline

Nov. 20, 2024

New cancer data analysis.

Value of a Chromatogram in Hemoglobin A1C Testing

Nov. 13, 2024

As diabetes management evolves, the use of advanced testing technologies like ion-exchange high-performance liquid chromatography (HPLC) for A1C (or HbA1c) testing has become ...

Diagnostics

Researchers use electronic diagnostic model to predict AIN in patients

LABline

Nov. 13, 2024

Johns Hopkins research.

Diagnostics

Detecting evidence of lung cancer in exhaled breath

LABline

Nov. 8, 2024

November is Lung Cancer Awareness Month.

PIQRAY® is a registered trademark of Novartis AG. VECTIBIX® is a registered trademark of Immunex Corporation. BRAFTOVI® is a registered trademark of Array BioPharma Inc. in the United States and various other countries. ERBITUX® is a registered trademark of ImClone LLC, a wholly owned subsidiary of Eli Lilly and Company. MEKINIST® is a registered trademark of Novartis AG Corporation Switzerland. KEYTRUDA® is a registered trademark of Merck. LENVIMA® (lenvatinib) is a registered trademark used by Eisai Inc. under license from Eisai R&D Management Co., Ltd.

Assays

Caris Life Sciences receives FDA approval for MI Cancer Seek as a companion diagnostic (CDx) test

LABline

Nov. 8, 2024

MI Cancer Seek is the first and only simultaneous whole exome and whole transcriptome-based assay with CDx indications for adults and pediatric patients.

Diagnostics

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics

LABline

Nov. 4, 2024

QIAstat-Dx Meningitis/Encephalitis Panel cleared in the U.S. for use in clinical settings to help diagnose central nervous system infections.

Diagnostics

Roche presents new data at CTAD

LABline

Oct. 31, 2024

New data highlight the potential of the Roche Elecsys Amyloid Plasma Panel and Elecsys ptau181 for ruling out Alzheimer’s disease related amyloid pathology with very good accuracy...

swab_pouch_on_kit_box_redacted_bjh03292024_zeptome

Diagnostics

Molecular quality controls in swab format

LABline

Oct. 31, 2024

ADLM round-up.

Diagnostics

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment

LABline

Oct. 30, 2024

QIAstat-Dx Respiratory Panel Mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions.